Self-amplifying mRNA vaccines.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Advances in Genetics

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/bs.adgen.2014.10.005PMID 25620012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytomegalovirus

  2016cited by this paper
• Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion.

  2015cited by this paper
• Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice.

  2014cited by this paper
• Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines

  2014cited by this paper
• A cationic nanoemulsion for the delivery of next-generation RNA vaccines.

  2014cited by this paper
• Mapping RNA structure in vitro using nucleobase-specific probes.

  2014cited by this paper
• A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs

  2014cited by this paper
• Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease.

  2014cited by this paper
• Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases

  2013cited by this paper
• Cytomegalovirus vaccines.

  2013cited by this paper
• Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques

  2013cited by this paper
• Nonreplicating vectors in HIV vaccines.

  2013cited by this paper
• Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice

  2013cited by this paper
• RNA replicon delivery via lipid-complexed PRINT protein particles.

  2013cited by this paper
• Priorities for CMV vaccine development.

  2013cited by this paper
• Vaccine delivery using nanoparticles

  2013cited by this paper
• Pre-existing immunity against vaccine vectors – friend or foe?

  2013cited by this paper
• Hepatitis C virus entry.

  2013cited by this paper
• A novel, disruptive vaccination technology

  2013cited by this paper
• The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination

  2013cited by this paper
• Advances in Lipid Nanoparticles for siRNA Delivery

  2013cited by this paper
• Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.

  2013cited by this paper
• Alphavirus Genome Delivery Occurs Directly at the Plasma Membrane in a Time- and Temperature-Dependent Process

  2013cited by this paper
• Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ

  2013cited by this paper
• The history of MF59® adjuvant: a phoenix that arose from the ashes

  2013cited by this paper
• The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect.

  2013cited by this paper
• Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses

  2013cited by this paper
• RNA: the new revolution in nucleic acid vaccines.

  2013cited by this paper
• Clinical development of Modified Vaccinia virus Ankara vaccines.

  2013cited by this paper
• Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies.

  2013cited by this paper
• Infection of cells by alphaviruses.

  2012cited by this paper
• Application of the whole-transcriptome shotgun sequencing approach to the study of Philadelphia-positive acute lymphoblastic leukemia

  2012cited by this paper
• What you always needed to know about electroporation based DNA vaccines

  2012cited by this paper
• The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.

  2012cited by this paper
• Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure.

  2012cited by this paper
• Nonviral delivery of self-amplifying RNA vaccines

  2012cited by this paper
• Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine?

  2012cited by this paper
• Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core

  2012cited by this paper
• Rendering protein-based particles transiently insoluble for therapeutic applications.

  2012cited by this paper
• Technologies for enhanced efficacy of DNA vaccines

  2012cited by this paper
• Artificial viruses: exploiting viral trafficking for therapeutics.

  2012cited by this paper
• Developments in rabies vaccines

  2012cited by this paper
• The mechanism of action of MF59 - an innately attractive adjuvant formulation.

  2012cited by this paper
• Lack of Interference with Immunogenicity of a Chimeric Alphavirus Replicon Particle-Based Influenza Vaccine by Preexisting Antivector Immunity

  2012cited by this paper
• Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

  2012cited by this paper
• Developing mRNA-vaccine technologies

  2012cited by this paper
• Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses

  2012cited by this paper
• Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans

  2012cited by this paper
• Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements

  2012cited by this paper
• Liposome-based delivery system for vaccine candidates: constructing an effective formulation.

  2012cited by this paper
• Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.

  2012cited by this paper
• Structural and functional insights into alphavirus polyprotein processing and pathogenesis

  2012cited by this paper
• Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis.

  2012cited by this paper
• Decoding Human Cytomegalovirus

  2012cited by this paper
• In vitro transcription of modified RNAs.

  2012cited by this paper
• Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses

  2012cited by this paper
• Analysis of lipid nanoparticles by Cryo-EM for characterizing siRNA delivery vehicles.

  2011cited by this paper
• Genetic Immunization with Plasmid DNA Mediated by Electrotransfer

  2011cited by this paper
• Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA

  2011cited by this paper
• Electroporation delivery of DNA vaccines: prospects for success.

  2011cited by this paper
• Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes.

  2011cited by this paper
• DNA vaccines: an historical perspective and view to the future

  2011cited by this paper
• Single-particle tracking as a quantitative microscopy-based approach to unravel cell entry mechanisms of viruses and pharmaceutical nanoparticles.

  2011cited by this paper
• RNA Replicons - A New Approach for Influenza Virus Immunoprophylaxis

  2010cited by this paper
• Genome-wide analysis of N1-methyl-adenosine modification in human tRNAs.

  2010cited by this paper
• Direct strand scission from a nucleobase radical in RNA.

  2010cited by this paper
• Rational design of cationic lipids for siRNA delivery

  2010cited by this paper
• Detection of RNA modifications

  2010cited by this paper
• Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein.

  2009cited by this paper
• Human Immune Memory to Yellow Fever and Smallpox Vaccination

  2009cited by this paper
• A structural and functional perspective of alphavirus replication and assembly.

  2009cited by this paper
• Role of 5′‐ and 3′‐untranslated regions of mRNAs in human diseases

  2009cited by this paper
• An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies.

  2009cited by this paper
• Novel Vaccines to Human Rabies

  2009cited by this paper
• DNA vaccine manufacture: scale and quality

  2009cited by this paper
• Electroporation of RNA stimulates immunity to an encoded reporter gene in mice.

  2009cited by this paper
• The many pathways of RNA degradation.

  2009cited by this paper
• Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.

  2009cited by this paper
• Sindbis virus replicon-based DNA vaccine encoding Rabies virus glycoprotein elicits specific humoral and cellular immune response in dogs.

  2009cited by this paper
• RNA-Seq: a revolutionary tool for transcriptomics

  2009cited by this paper
• Therapeutic and prophylactic applications of alphavirus vectors

  2008cited by this paper
• Induction of Broad CD4+ and CD8+ T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5

  2008cited by this paper
• Alum adjuvanticity: Unraveling a century old mystery

  2008cited by this paper
• The effect of particle design on cellular internalization pathways

  2008cited by this paper
• DNA vaccines: ready for prime time?

  2008cited by this paper
• Improving CMC-derivatization of pseudouridine in RNA for mass spectrometric detection.

  2008cited by this paper
• Vaccination with messenger RNA (mRNA).

  2008cited by this paper
• Molecular and cellular signatures of human vaccine adjuvants

  2008cited by this paper
• Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects.

  2008cited by this paper
• The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells1

  2008cited by this paper
• Identification of recognition residues for ligation-based detection and quantitation of pseudouridine and N6-methyladenosine

  2007cited by this paper
• Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection

  2007cited by this paper
• Surveillance of siRNA integrity by FRET imaging

  2007cited by this paper
• Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus

  2007cited by this paper
• Identification of modified residues in RNAs by reverse transcription-based methods.

  2007cited by this paper
• RNA analysis by MEKC with LIF detection

  2007cited by this paper
• Long-term storage of DNA-free RNA for use in vaccine studies.

  2007cited by this paper
• The highways and byways of mRNA decay

  2007cited by this paper
• Cationic liposomes as non‐viral carriers of gene medicines: Resolved issues, open questions, and future promises

  2007cited by this paper
• Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential

  2006cited by this paper

• Influence of the administration route and dose on the expression and antibody responses of a reporter and avian influenza self-amplifying mRNA vaccine in poultry

  2026influential citation
• Replicon RNA vaccines: design, delivery, and immunogenicity in infectious diseases and cancer

  2025cites this paper
• The Application of mRNA Technology for Vaccine Production—Current State of Knowledge

  2025cites this paper
• Impact of B18R-Encoding Messenger Ribonucleic Acid Co-Delivery on Neutralizing Antibody Production in Self-Amplifying Messenger Ribonucleic Acid Vaccines

  2025cites this paper
• A binary self-amplifying expression platform enabling lipid nanoparticle-free vaccines and nanomedicines

  2025cites this paper
• Q Fever Vaccines: Unveiling the Historical Journey and Contemporary Innovations in Vaccine Development

  2025cites this paper
• Cancer Vaccines: Molecular Mechanisms, Clinical Progress, and Combination Immunotherapies with a Focus on Hepatocellular Carcinoma

  2025cites this paper
• Awakening Sleeping Beauties from articles on mRNA vaccines against COVID-19

  2025cites this paper
• Advancements in delivering RNA therapies using physical transdermal drug delivery methods

  2025cites this paper
• DNA Vaccines in the Post-mRNA Era: Engineering, Applications, and Emerging Innovations

  2025cites this paper
• Recent Advances in mRNA-Based Vaccines Against Several Hepatitis Viruses

  2025cites this paper
• mRNA medicine: Recent progresses in chemical modification, design, and engineering

  2024cites this paper
• Lipid-based nanoparticles and their recent advances

  2024cites this paper
• Charge neutralized poly(β-amino ester) polyplex nanoparticles for delivery of self-amplifying RNA

  2024cites this paper
• Treatment and Prevention of HPV-Associated Skin Tumors by HPV Vaccination

  2024cites this paper
• RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection

  2024cites this paper
• A polyamino acid-based phosphatidyl polymer library for in vivo mRNA delivery with spleen targeting ability.

  2024cites this paper
• Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy

  2024cites this paper
• From Outbreaks to Artificial Intelligence: A Comprehensive Review of Monkeypox Virus Epidemiology, Diagnosis, Treatment, Vaccination, and Deep Learning Applications

  2024cites this paper
• mRNA vaccines: a new era in vaccine development

  2024cites this paper
• mRNA-based HIV-1 vaccines

  2024cites this paper
• An mRNA vaccine for pancreatic cancer designed by applying in silico immunoinformatics and reverse vaccinology approaches

  2024cites this paper
• Recent Findings on Therapeutic Cancer Vaccines: An Updated Review

  2024cites this paper
• Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness: Mechanisms and Future Outlook.

  2024cites this paper
• Advances in mRNA LNP-Based Cancer Vaccines: Mechanisms, Formulation Aspects, Challenges, and Future Directions

  2024cites this paper
• Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity

  2023cites this paper
• Biodegradable Polyester Nanoparticle Vaccines Deliver Self‐Amplifying mRNA in Mice at Low Doses

  2023cites this paper
• Navigating the horizon of mRNA vaccines: Tracing their evolution, ensuring safety, and unveiling therapeutic potential

  2023cites this paper
• Discovery and development of COVID‐19 vaccine from laboratory to clinic

  2023cites this paper
• Amplifying mRNA vaccines: potential versatile magicians for oncotherapy

  2023cites this paper
• In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future

  2023cites this paper
• Editorial: RNA machines

  2023cites this paper
• mRNA vaccine in cancer therapy: Current advance and future outlook

  2023cites this paper
• The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology.

  2023cites this paper
• Next-Generation TB Vaccines: Progress, Challenges, and Prospects

  2023cites this paper
• Liposomes: from August Wassermann to vaccines against COVID-19

  2023cites this paper
• Dendrimer-based Nanocomposites for the Production of RNA Delivery Systems

  2023cites this paper
• Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses

  2023cites this paper
• Non-interfacial self-assembly of synthetic protocells

  2023cites this paper
• Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development

  2023cites this paper
• mRNA vaccines: a transformative technology with applications beyond COVID‐19

  2022cites this paper
• Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects

  2022cites this paper
• Packaging, Purification, and Titration of Replication-Deficient Semliki Forest Virus-Derived Particles as a Self-Amplifying mRNA Vaccine Vector

  2022influential citation
• pDNA and mRNA vaccines

  2022cites this paper
• Modified mRNA-Based Vaccines Against Coronavirus Disease 2019

  2022cites this paper
• mRNA cancer vaccines: Advances, trends and challenges

  2022cites this paper
• Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach

  2022cites this paper
• The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA

  2022cites this paper
• Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy

  2022cites this paper
• The Nonmonotonic Dose Dependence of Protein Expression in Cells Transfected with Self-Amplifying RNA

  2022cites this paper
• Cancer vaccines as promising immuno-therapeutics: platforms and current progress

  2022cites this paper
• Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy

  2022cites this paper
• Licensed liposomal vaccines and adjuvants in the antigen delivery system

  2022cites this paper
• Nonclinical Safety Assessment of Lipid Nanoparticle-and Emulsion-Based Self-Amplifying mRNA Vaccines in Rats

  2022influential citation
• Construction and Application of Orthogonal T7 Expression System in Eukaryote: An Overview

  2022cites this paper
• Lipid carriers for mRNA delivery

  2022cites this paper
• Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment

  2022cites this paper
• A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database

  2022cites this paper
• [Progress on the development of the SARS-CoV-2 vaccine and antibody drugs].

  2022cites this paper
• Self-Amplifying RNA Approach for Protein Replacement Therapy

  2022cites this paper
• Oligonucleotide separation techniques for purification and analysis: What can we learn for today's tasks?

  2022cites this paper
• COVID‐19: Clinical status of vaccine development till date

  2022cites this paper
• A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies

  2022cites this paper
• Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity

  2022cites this paper
• Effects of Probiotics and Current Scenario of Fish Vaccination

  2022cites this paper
• mRNA vaccines in the prevention and treatment of diseases

  2022cites this paper
• Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases

  2022cites this paper
• Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives

  2022cites this paper
• Pandemic-response adenoviral vector and RNA vaccine manufacturing

  2021cites this paper
• DNA Vaccines: Methods and Protocols

  2021cites this paper
• Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination.

  2021cites this paper
• Design-of-Experiments In Vitro Transcription Yield Optimization of Self-Amplifying RNA

  2021cites this paper
• Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines

  2021influential citation
• Synthetic biology in the clinic: engineering vaccines, diagnostics, and therapeutics.

  2021cites this paper
• Conjugation of Mannans to Enhance the Potency of Liposome Nanoparticles for the Delivery of RNA Vaccines

  2021cites this paper
• mRNA vaccine: a potential therapeutic strategy

  2021cites this paper
• mRNA vaccine for cancer immunotherapy

  2021cites this paper
• Clinical and immunological effects of mRNA vaccines in malignant diseases

  2021cites this paper
• Perspectives on RNA Vaccine Candidates for COVID-19

  2021cites this paper
• In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?

  2021cites this paper
• Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape

  2021cites this paper
• Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273

  2021cites this paper
• Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action.

  2021cites this paper
• Polymeric Delivery of Therapeutic Nucleic Acids.

  2021cites this paper
• Innate Immunity Modulation during Zika Virus Infection on Pregnancy: What We Still Need to Know for Medical Sciences Breakthrough

  2021cites this paper
• Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines

  2021cites this paper
• Current development of Zika virus vaccines with special emphasis on virus-like particle technology

  2021cites this paper
• Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management

  2021cites this paper
• Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across

  2021influential citation
• Simultaneous transduction of dendritic cells with A20 and BTLA genes stimulates the development of stable and efficient tolerogenic dendritic cells and induces regulatory T cells.

  2021cites this paper
• Development of a 3D‐printed single‐use separation chamber for use in mRNA‐based vaccine production with magnetic microparticles

  2021cites this paper
• mRNA delivery via non-viral carriers for biomedical applications.

  2021cites this paper
• Polyplex nanomicelle delivery of self-amplifying RNA vaccine.

  2021cites this paper
• Agglomeration behaviour of magnetic microparticles during separation and recycling processes in mRNA purification

  2021cites this paper
• Towards a Prophylactic Vaccine for the Prevention of HCMV Infection

  2021cites this paper
• Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform

  2021cites this paper
• mRNA Vaccine Review against COVID-19 with Potential Applications to Improve Efficacy and Targeting

  2021cites this paper
• Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases

  2021cites this paper
• Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery.

  2021cites this paper
• A brief review on DNA vaccines in the era of COVID-19

  2021cites this paper